Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesamorelin and Exercise for Physical Function in HIV
NCT06554717Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2025
- Primary completion
- Jun 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of tesamorelin in human immunodeficiency virus infection (HIV), frailty syndrome, abdominal obesity, sponsored by Massachusetts General Hospital. Started Jul 2025; status: recruiting.
02
Drugs
tesamorelin
03
Conditions
human immunodeficiency virus infection (HIV)frailty syndromeabdominal obesity
Beyond the preview
Go deeper on NCT06554717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06554717.